Elizabeth A. Austin

1.5k total citations
19 papers, 1.2k citations indexed

About

Elizabeth A. Austin is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Elizabeth A. Austin has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Elizabeth A. Austin's work include Virus-based gene therapy research (5 papers), Cancer Research and Treatments (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Elizabeth A. Austin is often cited by papers focused on Virus-based gene therapy research (5 papers), Cancer Research and Treatments (3 papers) and Bacterial Genetics and Biotechnology (3 papers). Elizabeth A. Austin collaborates with scholars based in United States and Panama. Elizabeth A. Austin's co-authors include Brian E. Huber, C A Richards, Steven S. Good, Stephen T. Davis, Cynthia A. Richards, V C Knick, Doris M. Murray, Carl A. Schnaitman, David Porter and Craig T. Parker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Advanced Drug Delivery Reviews.

In The Last Decade

Elizabeth A. Austin

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth A. Austin United States 12 845 702 406 394 123 19 1.2k
Louis A. Zumstein United States 14 494 0.6× 818 1.2× 209 0.5× 492 1.2× 45 0.4× 21 1.2k
Erkko Ylösmäki Finland 18 391 0.5× 514 0.7× 269 0.7× 353 0.9× 53 0.4× 27 1.0k
Frances Toneguzzo Canada 16 332 0.4× 586 0.8× 155 0.4× 382 1.0× 147 1.2× 28 1.3k
Li-Mou Zheng China 15 420 0.5× 310 0.4× 748 1.8× 315 0.8× 28 0.2× 25 1.3k
Jesús Fominaya Spain 19 243 0.3× 743 1.1× 95 0.2× 179 0.5× 47 0.4× 33 1.0k
Markus Wolschek Austria 19 230 0.3× 947 1.3× 121 0.3× 219 0.6× 197 1.6× 34 1.4k
Łukasz Kuryk Poland 21 641 0.8× 687 1.0× 242 0.6× 568 1.4× 64 0.5× 61 1.4k
Andrew M. Lewis United States 27 1.2k 1.5× 1.2k 1.7× 87 0.2× 923 2.3× 117 1.0× 77 2.0k
Kazuyuki Takai Japan 21 204 0.2× 1.3k 1.8× 105 0.3× 98 0.2× 112 0.9× 103 1.6k
Kristina Cunningham United States 12 452 0.5× 718 1.0× 164 0.4× 75 0.2× 32 0.3× 17 955

Countries citing papers authored by Elizabeth A. Austin

Since Specialization
Citations

This map shows the geographic impact of Elizabeth A. Austin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Austin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Austin more than expected).

Fields of papers citing papers by Elizabeth A. Austin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Austin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Austin. The network helps show where Elizabeth A. Austin may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Austin

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Austin. A scholar is included among the top collaborators of Elizabeth A. Austin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Austin. Elizabeth A. Austin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Austin, Elizabeth A., et al.. (2018). Pediatric Perioperative Nurses and the Ethics of Organ Donation After Cardiac Death. AORN Journal. 107(4). e1–e8. 4 indexed citations
2.
Austin, Elizabeth A.. (2016). Personalized care for families of perioperative patients. AORN Journal. 103(3). P13–4. 2 indexed citations
3.
4.
Wicklin, Sharon Ann Van, et al.. (2007). Reviews. AORN Journal. 86(4). 675–678. 1 indexed citations
5.
Bynum, Jane M., et al.. (1999). Development of Class-Switched, Affinity-Matured Monoclonal Antibodies Following a 7-Day Immunization Schedule. Hybridoma. 18(5). 407–411. 11 indexed citations
6.
Pascale, Juan Miguel, et al.. (1997). Immunological markers of disease progression in patients infected with the human immunodeficiency virus. Clinical and Diagnostic Laboratory Immunology. 4(4). 474–477. 16 indexed citations
7.
Richards, Cynthia A., Elizabeth A. Austin, & Brian E. Huber. (1995). Transcriptional Regulatory Sequences of Carcinoembryonic Antigen: Identification and Use with Cytosine Deaminase for Tumor-Specific Gene Therapy. Human Gene Therapy. 6(7). 881–893. 130 indexed citations
8.
Huber, Brian E., Cynthia A. Richards, & Elizabeth A. Austin. (1995). VDEPT: An enzyme/prodrug gene therapy approach for the treatment of metastatic colorectal cancer. Advanced Drug Delivery Reviews. 17(3). 279–292. 21 indexed citations
9.
Austin, Elizabeth A., et al.. (1995). Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.. PubMed. 55(21). 4808–12. 150 indexed citations
10.
Huber, Brian E., Cynthia A. Richards, & Elizabeth A. Austin. (1994). Virus‐Directed Enzyme/Prodrug Therapy (VDEPT) Selectively Engineering Drug Sensitivity into Tumors. Annals of the New York Academy of Sciences. 716(1). 104–114. 37 indexed citations
11.
Huber, Brian E., Elizabeth A. Austin, C A Richards, Stephen T. Davis, & Steven S. Good. (1994). Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.. Proceedings of the National Academy of Sciences. 91(17). 8302–8306. 340 indexed citations
12.
Porter, David & Elizabeth A. Austin. (1993). Cytosine deaminase. The roles of divalent metal ions in catalysis.. Journal of Biological Chemistry. 268(32). 24005–24011. 43 indexed citations
13.
Austin, Elizabeth A. & Brian E. Huber. (1993). A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.. Molecular Pharmacology. 43(3). 380–387. 143 indexed citations
14.
Austin, Elizabeth A. & Brian E. Huber. (1993). Localization of the codA gene on the Escherichia coli chromosome. Journal of Bacteriology. 175(11). 3685–3686. 3 indexed citations
15.
Huber, Brian E., et al.. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.. PubMed. 53(19). 4619–26. 189 indexed citations
16.
Schnaitman, Carl A. & Elizabeth A. Austin. (1990). Efficient incorporation of galactose into lipopolysaccharide by Escherichia coli K-12 strains with polar galE mutations. Journal of Bacteriology. 172(9). 5511–5513. 16 indexed citations
17.
Austin, Elizabeth A., et al.. (1990). Genetic analysis of lipopolysaccharide core biosynthesis by Escherichia coli K-12: insertion mutagenesis of the rfa locus. Journal of Bacteriology. 172(9). 5312–5325. 89 indexed citations
18.
Bird, Thomas D., et al.. (1980). Developmental dissociation of myelin synthesis and ?myelin-associated? enzyme activities in the shiverer mouse. Neurochemical Research. 5(8). 885–895. 6 indexed citations
19.
Baecker, Preston A., et al.. (1978). Periplasmic localization of nicotinate phosphoribosyltransferase in Escherichia coli. Journal of Bacteriology. 133(3). 1108–1112. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis A. Zumstein Breakdown of academic impact, for papers by Erkko Ylösmäki Breakdown of academic impact, for papers by Frances Toneguzzo Breakdown of academic impact, for papers by Li-Mou Zheng Breakdown of academic impact, for papers by Jesús Fominaya Breakdown of academic impact, for papers by Markus Wolschek Breakdown of academic impact, for papers by Łukasz Kuryk Breakdown of academic impact, for papers by Andrew M. Lewis Breakdown of academic impact, for papers by Kazuyuki Takai Breakdown of academic impact, for papers by Kristina Cunningham
Rankless by CCL
2026